| Literature DB >> 34782783 |
Yi Duan1,2, Ry Young3,4,5, Bernd Schnabl6,7,8.
Abstract
Although bacteriophages have been overshadowed as therapeutic agents by antibiotics for decades, the emergence of multidrug-resistant bacteria and a better understanding of the role of the gut microbiota in human health and disease have brought them back into focus. In this Perspective, we briefly introduce basic phage biology and summarize recent discoveries about phages in relation to their role in the gut microbiota and gastrointestinal diseases, such as inflammatory bowel disease and chronic liver disease. In addition, we review preclinical studies and clinical trials of phage therapy for enteric disease and explore current challenges and potential future directions.Entities:
Mesh:
Year: 2021 PMID: 34782783 PMCID: PMC8966578 DOI: 10.1038/s41575-021-00536-z
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN: 1759-5045 Impact factor: 46.802